PROCEPT BioRobotics names Larry Wood as new CEO
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/26/2026
- Nasdaq lags on angst over AI spending ahead of earnings reports
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Oil falls on report China pushing for end US-Iran war
- Why Meta, Microsoft, and Nvidia are championing open-weight AI
- FDA approves Tylenol with Naproxen as first OTC combo pain reliever
- AMD (AMD) PT Raised to $1,250 at Baird
- Pakistan, Iran explore path towards new talks with US in a China-initiated push, sources say
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Nasdaq lags on angst over AI spending ahead of earnings reports
BTIG Reiterates Neutral Rating on Procept BioRobotics Corp (PRCT)
July 25, 2025 5:52 AM EDTBTIG analyst Ryan Zimmerman reiterated a Neutral rating on Procept BioRobotics Corp (NASDAQ: PRCT).
The analyst comments "PRCT announced CEO Reza Zadno will retire as President, CEO, and Director effective Sept. 1, 2025. Larry Wood, who was most recently VP and Group President of TAVR and Structural Heart at Edwards Lifesciences (EW, Neutral, Thibault), has been appointed as the new CEO. Additionally, PRCT preannounced preliminary 2Q25 results with rev.... More
